BioDlink International Company Limited

HK$3.47As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1875Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 7Y CAGR (5.48%)
Div yield —
ROE (24.21%)
Biotechnology
Beta (5Y) (0.14)
PE TTM —
TSR TTM 74.37%
Mkt cap HK$2.682B
ROIC (8.53%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.43
27.56%
(70.46%)
Hold 12|10|8|11|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.04
0.04
0.04
0.05
27.02%
19.00%
20.50%
22.29%
Revenue¥M
125.4
123.9
125.4
122.4
(1.21%)
(0.84%)
1.16%
(3.82%)
Peers (US$342.5M)
Cap (US$)
PE
386.6M
36.53x
353.6M
16.80x
328.9M
—
Capital
TTM
5Y
10Y
Leveragex
0.423
0.211
0.197
EBIT/Intx
7.180
0.390
0.420
Own earn%
(4.48)
(139.76)
(154.96)
Sh yield%
46.83
24.96
24.24
Owners
Insiders/Inst%
2.70
84.40
Short interest%
4.27
SBC / revenue%
4.29
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
10–15
$1 testx
0.0
Incr. ROIC%
6